SNYR (Synergy CHC Corp.) Company Cash Volume

Official company branding of Synergy CHC Corp (SNYR)

Synergy CHC Corp (SNYR) relies on decentralization by outsourcing logistics and product manufacturing to external contractors. Operating cash flow confirms this strategy, where the value of 0.00 denotes the current liquidity metric. A stable roster of brand managers minimizes hiring, while asset growth is driven by the acquisition of niche health food and cosmetics brands through partnerships with retailers.

Synergy CHC - SNYR Company Cash Reserve (period 10/24/2024 - 10/03/2026)

Metric breakdowns and analytics for Synergy CHC Corp (SNYR)

- stock value and consensus price forecast:
Fundamental valuation:Synergy CHC Corp
Brand item of Synergy CHC Corporation

This indicator measures the liquid asset reserve serving as a defensive buffer, although excessive cash stagnation may indicate a decline in capital management efficiency. By analyzing the company's cash resources, an investor assesses the ability of Synergy CHC Corp (SNYR) to fund creative e-commerce strategies and pay employee bonuses for sales growth without resorting to costly external loans.

Competitors of Synergy CHC Corp

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|Company Cash Funds BioHarvest Sciences BHST|EXOZ (Invizyne) - Company Total Cash Volume|ORMP: Company Cash on Hand|ENTX (Entera Bio Ltd) - Company Cash and Cash Equivalents|HYFT: Company Cash Volume|Company Cash on Hand ABVC BioPharma Inc.|CPIX (cumberlandpharma.com) - Company Cash Volume|Company Cash Funds QNTM|Company Cash Volume FGEN|Company Cash on Hand Telomir Pharmaceuticals TELO|Company Cash Volume RANI (ranitherapeutics.com)|Company Cash Balance RLYB|LEXX: Company Cash on Hand|Company Cash Balance PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance